You have 9 free searches left this month | for more free features.

Thrombocytosis

Showing 1 - 25 of 534

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Molecular Biology of Polycythemia and Thrombocytosis

Recruiting
  • Polycythemia
  • Thrombocytosis
    • Salt Lake City, Utah
      University of Utah
    Dec 28, 2022

    Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2023

    The Role of Circ0014614 in the Formation and Development of ET

    Recruiting
    • Primary Thrombocytosis
      • Guangzhou, Guangdong, China
        Department of Hematology,Nanfang Hospital, Southern Medical Univ
      Jun 18, 2023

      Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

      Completed
      • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      May 27, 2022

      Real World Evidence of Fedratinib Effectiveness in MF

      Not yet recruiting
      • Primary Myelofibrosis
      • +2 more
      • (no location specified)
      May 22, 2023

      Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

      Not yet recruiting
      • Myeloproliferative Disorders
      • +3 more
      • (no location specified)
      Nov 21, 2023

      Assess the Safety of Fedratinib in Korean Myelofibrosis

      Recruiting
      • Primary Myelofibrosis
      • +2 more
      • Seoul, Korea, Republic of
        Bristol-Myers Squibb YH
      Oct 3, 2023

      Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

      Recruiting
      • Myeloproliferative Neoplasm
      • +7 more
        • Hong Kong, Hong Kong
          Department of Medicine, Queen Mary Hospital
        May 21, 2023

        Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

        Not yet recruiting
        • Myelofibrosis (PMF)
        • +2 more
        • New York, New York
          Ruttenberg Treatment Center
        Apr 18, 2023

        Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

        Not yet recruiting
        • Essential Thrombocythemia
        • (no location specified)
        Oct 6, 2023

        Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

        Active, not recruiting
        • Myeloproliferative Neoplasm
        • +4 more
        • Orange, California
          Chao Family Comprehensive Cancer Center, University of Californi
        Jan 6, 2023

        Myeloproliferative Tumor, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage Trial (CALR allele burden

        Recruiting
        • Myeloproliferative Neoplasm
        • +3 more
        • CALR allele burden quantification
        • Angers, France
          CHU Angers
        Nov 2, 2022

        Essential Thrombocythemia Trial (Ropeginterferon alfa-2b-njft (P1101))

        Not yet recruiting
        • Essential Thrombocythemia
        • Ropeginterferon alfa-2b-njft (P1101)
        • (no location specified)
        Jul 28, 2022

        Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

        Recruiting
        • Primary Myelofibrosis
        • +4 more
        • New York, New York
          Ruttenberg Treatment Center
        Jul 18, 2022

        Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

        Recruiting
        • Essential Thrombocytopenia
        • Recombinant Interferon Alpha
        • Pegylated interferon alfa-2b
        • Tianjin, Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        Jul 18, 2022

        Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

        Not yet recruiting
        • Myelofibrosis
        • +2 more
        • Peptide-based vaccine
        • Poly ICLC
        • New York, New York
          Icahn School of Medicine at Mount Sinai
        Jun 7, 2022

        Polycythemia Vera, Essential Thrombocythemia, and

        Not yet recruiting
        • Myeloproliferative Neoplasm
        • Next-generation sequencing
        • (no location specified)
        Jun 27, 2022

        Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

        Terminated
        • Primary Myelofibrosis (PMF)
        • +2 more
        • Larkspur, California
        • +2 more
        Nov 14, 2022

        Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

        Not yet recruiting
        • Clonal Cytopenia of Undetermined Significance
        • +4 more
        • Biospecimen Collection
        • +6 more
        • Los Angeles, California
        • +1 more
        Oct 4, 2023

        Arterial Function and Atherosclerosis in Essential

        Completed
        • Atherosclerosis
        • imaging
        • (no location specified)
        Oct 6, 2021

        Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

        Recruiting
        • Myelofibrosis; Anemia
        • +5 more
        • Jacksonville, Florida
        • +6 more
        Jan 3, 2023

        Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

        Recruiting
        • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 18, 2022

        Primary Myelofibrosis (PMF), Post Polycythemia Myelofibrosis (PPV MF), Thrombocythemia Myelofibrosis (PET-MF) Trial

        Available
        • Primary Myelofibrosis (PMF)
        • +2 more
        • (no location specified)
        Jan 18, 2022

        Thrombocythemia, Essential Trial in San Antonio (IMG-7289)

        Recruiting
        • Thrombocythemia, Essential
        • San Antonio, Texas
          Mays Cancer Center
        Dec 14, 2021

        Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)

        Terminated
        • Essential Thrombocythemia
        • +2 more
        • Arsenic Trioxide
        • +3 more
        • Buffalo, New York
          Roswell Park Cancer Institute
        Jul 20, 2022